It wasn't hard to be more positive on Integer's prospects. The company grew sales by 5% year over year to $472 million in its ...
Delivered 8% sales growth and 21% adjusted EPS growth in full year 2025 ~ ~ 2026 Outlook maintains midpoint of sales growth ...
Medical technology company Integer Holdings (NYSE:ITGR) reported Q4 CY2025 results , with sales up 5% year on year to $472.1 ...
Fintel reports that on February 20, 2026, Benchmark upgraded their outlook for Integer Holdings (NYSE:ITGR) from Hold to Buy.
Shares of Integer Holdings rose after the company reported sales growth in the fourth quarter and issued full-year guidance above Wall Street's expectations. Shares were up 3.8% to $89.51 late ...
Shares of Integer (NYSE: ITGR), a company specializing in the development and manufacturing of medical devices, saw a substantial decline of 32% on October 23, 2025. This notable drop was mainly due ...
The Plano, Texas-based company said it had net income of $1.38 per share. Earnings, adjusted for one-time gains and costs, came to $1.76 per share. The results topped Wall Street expectations. The ...
Detailed price information for Integer Holdings Corp (ITGR-N) from The Globe and Mail including charting and trades.